Profound Medical Corp. (PROF): Price and Financial Metrics
GET POWR RATINGS... FREE!
PROF POWR Grades
- Growth is the dimension where PROF ranks best; there it ranks ahead of 48.01% of US stocks.
- The strongest trend for PROF is in Value, which has been heading up over the past 47 weeks.
- PROF ranks lowest in Quality; there it ranks in the 5th percentile.
PROF Stock Summary
- PROF's went public 1.88 years ago, making it older than just 3.12% of listed US stocks we're tracking.
- With a price/sales ratio of 48.8, Profound Medical Corp has a higher such ratio than 94.97% of stocks in our set.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.07 for Profound Medical Corp; that's greater than it is for just 6.32% of US stocks.
- Stocks that are quantitatively similar to PROF, based on their financial statements, market capitalization, and price volatility, are ATNX, GPL, RDUS, CYRN, and AKBA.
- Visit PROF's SEC page to see the company's official filings. To visit the company's web site, go to www.profoundmedical.com.
PROF Price Target
For more insight on analysts targets of PROF, see our PROF price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $26.60 | Average Broker Recommendation | 1.4 (Strong Buy) |
PROF Stock Price Chart Interactive Chart >
PROF Price/Volume Stats
| Current price | $14.62 | 52-week high | $28.97 |
| Prev. close | $14.44 | 52-week low | $13.43 |
| Day low | $14.19 | Volume | 32,500 |
| Day high | $14.79 | Avg. volume | 68,843 |
| 50-day MA | $15.17 | Dividend yield | N/A |
| 200-day MA | $19.40 | Market Cap | 298.06M |
Profound Medical Corp. (PROF) Company Bio
Profound Medical Corp. operates as a medical device company. The Company develops and commercializes technology for the treatment of localized prostate cancer. Profound Medical offers its services worldwide.
Latest PROF News From Around the Web
Below are the latest news stories about Profound Medical Corp that investors may wish to consider to help them evaluate PROF as an investment opportunity.
Profound Medical to Participate in September Virtual Investor ConferencesTORONTO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announce today that management will participate in two investor conferences in September. Lake Street’s 5th Annual Best Ideas Growth Conference: Profound is scheduled to participate in a series of one-on-one meetings on September 15, 20 |
We're Not Worried About Profound Medical's (TSE:PRN) Cash BurnThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com... |
Profound Medical Announces Second Quarter 2021 Financial ResultsTORONTO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today reported financial results for the second quarter ended June 30, 2021. Recent Corporate Highlights On April 21, 2021, the Company participated in the 2021 Bloom Burton & Co. Virtual Healthcare Investor Conference.On May 6, 2021, Pr |
PROFOUND MEDICL (PROF) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleasePROFOUND MEDICL (PROF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
Profound Medical to Participate in A.G.P.’s Virtual MedTech Summer ConferenceTORONTO, July 22, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announced today that management will participate in A.G.P.’s Virtual MedTech Summer Conference on Thursday, July 29, 2021. The event will consist of one-on-one virtual investor meetings. Due to the format of the event, no webcast will be |
PROF Price Returns
| 1-mo | -0.68% |
| 3-mo | -20.63% |
| 6-mo | -30.15% |
| 1-year | -13.95% |
| 3-year | 148.64% |
| 5-year | N/A |
| YTD | -28.89% |
| 2020 | 87.76% |
| 2019 | 160.71% |
| 2018 | -35.64% |
| 2017 | N/A |
| 2016 | N/A |
Loading social stream, please wait...